Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
CP

Christopher P. Price — 14 Patents

BPBiomarin Pharmaceutical: 9 patents #17 of 139Top 15%
PBPublic Health Laboratory Service Board: 3 patents #3 of 46Top 7%
MAMicrobiological Research Authority: 1 patents #11 of 20Top 60%
Bristol-Myers Squibb: 1 patents #2,493 of 3,969Top 65%
Overall (All Time): #332,869 of 4,157,543Top 9%
14 Patents All Time
Christopher P. Price has been granted 14 US patents while listed as an inventor at Biomarin Pharmaceutical. The first was granted in 1983 and the most recent in September 2024. Christopher P. Price ranks #332,869 of 4,157,543 US inventors in our database (top 8.0%). Patent records list Christopher P. Price in Aachen, CA, DE.

Patents per Year

Patents granted per year, 1983 to 2024Bar chart with a peak of 2 patents in 2012.peak 21983: 1 patents19831984: 1 patents19841995: 1 patents19951998: 1 patents19982012: 2 patents20122013: 1 patents20132018: 2 patents20182020: 2 patents20202023: 1 patents20232024: 2 patents2024

Issued Patents All Time

Showing 1–14 of 14 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
12076372 Use of C-type natriuretic peptide variants to treat skeletal dysplasia Sherry Bullens, Stuart Bunting, Tianwei Chou, Augustus O. Okhamafe, Daniel J. Wendt +1 more 2024-09-03 $110,987,000
11911446 Use of C-type natriuretic peptide variants to treat skeletal dysplasia Sherry Bullens, Stuart Bunting, Tianwei Chou, Augustus O. Okhamafe, Daniel J. Wendt +1 more 2024-02-27 $103,753,000
11590204 Use of C-type natriuretic peptide variants to treat skeletal dysplasia Sherry Bullens, Stuart Bunting, Tianwei Chou, Augustus O. Okhamafe, Daniel J. Wendt +1 more 2023-02-28 $127,550,000
RE48267 Variants of C-type natriuretic peptide Daniel J. Wendt, Shinong Long, Sianna Castillo, Mika Aoyagi-Scharber, Michel Claude Vellard +1 more 2020-10-20
10646550 Use of C-type natriuretic peptide variants to treat skeletal dysplasia Sherry Bullens, Stuart Bunting, Tianwei Chou, Augustus O. Okhamafe, Daniel J. Wendt +1 more 2020-05-12 $121,040,000
9907834 Use of C-type natriuretic peptide variants to treat skeletal dysplasia Sherry Bullens, Stuart Bunting, Tianwei Chou, Augustus O. Okhamafe, Daniel J. Wendt +1 more 2018-03-06 $43,215,000
RE46707 Variants of C-type natriuretic peptide Daniel J. Wendt, Shinong Long, Sianna Castillo, Mika Aoyagi-Scharber, Michel Claude Vellard +1 more 2018-02-13
8598121 Variants of C-type natriuretic peptide Daniel J. Wendt, Shinong Long, Sianna Castillo, Mika Aoyagi-Scharber, Michel Claude Vellard +1 more 2013-12-03 $71,322,000
8252821 Bioavailable capsule compositions of amorphous alpha-(N-sulfonamido)acetamide compound Sachin Chandran, Rajesh Gandhi, Jaquan Kalani Levons, Robert Kevin Perrone, Krishnaswamy Srinivas Raghavan +1 more 2012-08-28 $87,514,000
8198242 Variants of C-type natriuretic peptide Daniel J. Wendt, Shinong Long, Sianna Castillo, Mika Aoyagi-Scharber, Michel Claude Vellard +1 more 2012-06-12 $31,144,000
5714364 Phenylalanine dehydrogenase production Peter Hammond, Graham Mark Brearley 1998-02-03
5460948 Assay of salicylates or reduced pyridine nucleotides Anthony Atkinson, Stewart R. Cambell, Peter Hammond, Helen C. Morris, John R. Ramsey 1995-10-24
4430433 Production of aryl acylamidases Peter Hammond, Michael D. Scawen 1984-02-07
4414327 Method for the estimation of N-acylated primary aromatic amines Peter Hammond, Michael D. Scawen, Anthony Atkinson 1983-11-08